SCHEDULE: Vanguard Group Reports 0% Glaukos Corp Stake After Realignment

The Vanguard Group has amended its Schedule 13G filing for Glaukos Corp, reporting 0% beneficial ownership following an internal realignment where subsidiaries will now report separately.

Summary

• The Vanguard Group filed an Amendment No. 3 to its Schedule 13G for Glaukos Corp, indicating a change in its beneficial ownership reporting.
• The filing states that The Vanguard Group now beneficially owns 0% of Glaukos Corp's Common Stock, with 0 sole or shared voting and dispositive power.
• This change is a result of an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis).
• Consequently, The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by these subsidiaries and/or business divisions.
• The CUSIP number for Glaukos Corp Common Stock is 377322102.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative update regarding an institutional investor's reporting structure, rather than a direct positive or negative indicator for Glaukos Corp's operational performance or financial health.

Positives

• The internal realignment by The Vanguard Group may lead to more granular and disaggregated reporting of beneficial ownership by its subsidiaries, potentially offering clearer insights into specific investment strategies within the broader Vanguard family.

Negatives

• The Vanguard Group, as the specific reporting entity in this filing, now reports 0% beneficial ownership of Glaukos Corp, representing a reduction from its previously reported holdings.

Risks

• There is a potential for market misinterpretation regarding The Vanguard Group's reported 0% ownership, which could lead to unwarranted speculation about the underlying investment in Glaukos Corp, despite the explanation of an internal realignment.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding Glaukos Corp's business or financial performance.

Industry Context

StockSavvy.ai notes that this administrative filing reflects an internal restructuring within The Vanguard Group, a common practice among large asset managers to optimize reporting structures or align with specific investment mandates. While it changes the reporting entity for Glaukos Corp shares, it does not necessarily indicate a change in the overall investment thesis or holdings by the broader Vanguard family of funds, as subsidiaries will now report separately.

Comparison to Industry Standards

• This filing is an administrative update regarding an institutional investor's beneficial ownership reporting and does not contain performance metrics for Glaukos Corp that would allow for a comparison to industry standards or specific comparable companies/projects.

Stakeholder Impact

• Shareholders of Glaukos Corp may experience short-term uncertainty or misinterpretation regarding The Vanguard Group's reported 0% ownership, potentially leading to minor stock price fluctuations.
• The Vanguard Group is impacted by this internal realignment, which shifts its beneficial ownership reporting obligations for Glaukos Corp shares to its subsidiaries.

Key Dates

Keywords

Glaukos Corp, Vanguard Group, Schedule 13G, Beneficial Ownership, SEC Filing, Institutional Investor, Common Stock, Investment Realignment, Ownership Change